Table 3.
Multi-lineage cell culture media.
| Media | Composition |
|---|---|
| Osteogenic induction media | DMEM: F12 |
| 10% FBS | |
| 1% penicillin–streptomycin | |
| 1% antibiotic–antimycotic | |
| 10 nM dexamethasone | |
| 10 mM β-glycerol phosphate | |
| 50 µg/ml ascorbic-acid-2-phospahate | |
| Osteogenic maintenance media | DMEM: F12 |
| 10% FBS | |
| 1% penicillin–streptomycin | |
| 1% antibiotic–antimycotic | |
| 10 nM dexamethasone | |
| 5 mM β-glycerol phosphate | |
| 50 µg/ml ascorbic-acid-2-phospahate | |
| Adipogenic induction media | DMEM: F12 |
| 10% FBS | |
| 1% penicillin–streptomycin | |
| 1% antibiotic–antimycotic | |
| 10 µg/ml insulin | |
| 1 µM dexamethasone | |
| 500 µM 3-isobutyl-1-methylxanthine | |
| Adipogenic maintenance media | DMEM: F12 |
| 10% FBS | |
| 1% penicillin–streptomycin | |
| 1% antibiotic–antimycotic | |
| 10 µg/ml insulin | |
| Chondrogenic induction media | DMEM: F12 |
| 10% FBS | |
| 1% penicillin–streptomycin | |
| 1% antibiotic–antimycotic | |
| 10 nM dexamethasone | |
| 50 µg/ml ascorbic-acid-2-phospahate | |
| 10 ng/ml recombinant human TGF-β3 | |
| 40 μg/ml l-proline | |
| 50 μg/ml ITS liquid media supplement |